2023年4月21日

Caristo诊断有限公司——全球领先的心脏和血管疾病诊断和风险预测-进一步宣布,它已获得£1300万(1630万美元)来总结其首轮融资。资金是由牛津大学科学企业和整编,长壁Venture Partners,牛津投资顾问LLP),牛津大学和其他投资者。心血管疾病(心血管病)被称为全球死亡的首要原因,每年估计近1800万人的生命。和Caristo旨在改变这统计通过交付其先进的冠状动脉疾病的诊断技术。CaRi-Heart AI算法允许训练有素的卫生专业人员获取冠状动脉炎症指标从常规心脏电脑断层血管造影(CCTA)扫描通过Caristo脂肪衰减指数(FAI)技术。和由此产生的FAI分数措施由于冠状动脉炎症心脏疾病而死亡的风险。+ CaRi-Heart提供了一个长期的心脏死亡风险通过整合冠状动脉炎症与标准临床危险因素与冠状动脉斑块的存在。资金将用于:Caristo将使用资本推动其CaRi-Heart技术、AI-assisted诊断,心脏保健和风险预测工具,标准在全球主要市场。关键引用:“我们感到欣慰的是,五个成功的机构投资者参与融资轮验证Caristo大量临床和商业潜力的创新。我们是同样的兴奋地欢迎弗兰克程Caristo的新CEO。 Frank led multiple digital health companies during the last twenty years, and most recently was President & CCO of Eyenuk, Inc, a diagnostic company with autonomous AI technology that was FDA-cleared, Medicare-reimbursed, supported by a new Category 1 CPT code, and adopted in eighteen countries. With a portfolio of novel technologies, exceptional clinical results and an experienced management team, Caristo is well positioned to transform healthcare around the world.” – Oran Muduroglu, Board Chairman of Caristo “We invest in companies with the potential to revolutionize healthcare and become global category leaders and that is why we are proud to back the incredible team at Caristo. Caristo continues to make tremendous progress in the delivery of its innovative technology to help healthcare professionals predict and prevent future heart attacks and ultimately save millions of lives around the world. We are thrilled to continue being part of the company’s journey.” – Heather Roxborough, Head of HealthTech at Oxford Science Enterprises and Caristo Board Member “Caristo has been on an exciting journey since 2018 as the Company turned a scientific idea into a validated clinical offering, protected our intellectual property, published impressive results in leading peer-reviewed medical journals, and secured initial regulatory approvals. Our Series A fundraise will accelerate Caristo’s growth in our existing UK and EU markets, while we lay solid foundations for U.S. market entry.” – Frank Cheng, Caristo CEO and Board Member Trending on Pulse 2.0